CD19 Antikörper
-
- Target Alle CD19 Antikörper anzeigen
- CD19 (CD19 Molecule (CD19))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD19 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunofluorescence (IF)
- Aufreinigung
- Protein G affinity chromatography
- Immunogen
- Human CD19 recombinant protein was used as immunogen for this CD19 antibody.
- Klon
- C19-366
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product CD19 Primärantikörper
-
anti-CD19 Molecule (CD19) (AA 485-556) antibody
CD19 Reaktivität: Human, Maus, Ratte, Schaf FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 151-250) antibodyCD19 Reaktivität: Human, Maus, Ratte FACS, WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 20-291) antibodyCD19 Reaktivität: Human FACS, WB, IHC, ELISA, IF Wirt: Maus Monoclonal 8G11B7 unconjugated
anti-CD19 Molecule (CD19) (C-Term) antibodyCD19 Reaktivität: Human, Maus, Affe, Ratte, Schaf, Schwein, Rind (Kuh), Meerschweinchen, Hund, Esel, Ziege, Hamster, Pferd, Kaninchen, Avian, Cat, Huhn WB Wirt: Ziege Polyclonal unconjugated
anti-CD19 Molecule (CD19) (pTyr531) antibodyCD19 Reaktivität: Human, Maus FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reaktivität: Human FACS, WB, IF, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 96-281) antibodyCD19 Reaktivität: Human FACS, IHC, ELISA, Coat, StM Wirt: Maus Monoclonal CD19-3116 unconjugated
anti-CD19 Molecule (CD19) (AA 143-172) antibodyCD19 Reaktivität: Human FACS, WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 160-258) antibodyCD19 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reaktivität: Human FACS, IP Wirt: Maus Monoclonal LT19 unconjugated
-
- Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/million cells
Immunofluorescence: 0.5-1 μg/mL
Variations in protocols, secondaries and substrates may require the CD19 antibody to be titered up or down for optimal performance. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
- Target
- CD19 (CD19 Molecule (CD19))
- Andere Bezeichnung
- CD19 (CD19 Produkte)
- Synonyme
- B4 antikoerper, CVID3 antikoerper, AW495831 antikoerper, CD19 antikoerper, CD19 molecule antikoerper, CD19 antigen antikoerper, CD19 antikoerper, Cd19 antikoerper
- Hintergrund
- CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
- Gen-ID
- 930
- UniProt
- P15391
- Pathways
- Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung
-
